The Sexual Health Inventory for Men (SHIM) is a widely used scale for screening and diagnosis of erectile dysfunction (ED) and severity of ED in clinical practice and research. In reviewing the SHIM-related literature, we sought to provide a compendium of studies in which the SHIM was used, to provide a systematic framework for organizing and evaluating the studies, and to provide a status report on the SHIM and its impact on the management of male sexual dysfunction. Using a Medline search, we found that the SHIM was an integral measure in at least 21 studies on the prevalence of ED, 23 studies on the efficacy of ED interventions, and eight other (mainly correlational) studies. The quantity of research and quality of scholarship on the SHIM provide testimony to its positive impact on understanding and improving male sexual function. These scientific contributions are likely to remain influential in coming years.
Introduction
Erectile dysfunction (ED) affects a large proportion of the adult male population. The International Index of Erectile Function (IIEF) is a widely used, multidimensional self-report instrument for the evaluation of male sexual function. 1, 2 The development and validation of the IIEF have been reported elsewhere.
1,2 Briefly, the IIEF, which consists of 15 items and five domains, is a psychometrically valid and reliable instrument that was developed through consultations with an international panel of experts for use in determining efficacy of treatment in controlled clinical trials. The IIEF has high sensitivity for detecting real treatment effects and has been adopted as the gold standard treatment outcome measure for clinical trials in ED, regardless of the type of treatment intervention or study population under investigation. Designed originally and specifically for use in clinical trials, the full-scale IIEF required simplification and abbreviation in order to be adopted in broad clinical practice as a diagnostic measure for ED or as a simple office screening tool.
The National Institutes of Health's Consensus Panel on ED outlined several goals for basic and clinical research on ED. 3 One of these goals was to create a staging system for the quantitative and qualitative classification of ED to improve clinical decision making and patient care. With this purpose in mind, an abridged five-item version of the 15-item IIEF known as the IIEF-5-or the Sexual Health Inventory for Men (SHIM)-was developed and validated as a brief, easily administered, patientreported diagnostic tool (Table 1) . 4 Diagnostic evaluations of the SHIM have shown it to have high sensitivity and specificity, moderate-tohigh correlations with (and better reliability than) a single-item self-assessment of ED severity, and tangible correlations (as expected) with improvement in erections and with treatment satisfaction for both patient and partner. 4, 5 The SHIM, which, like the original IIEF, has been translated into more than 30 languages, is widely used as a screening measure in clinical practice settings in the United States and other countries SUBJECT INITIALS:_________ DATE COMPLETED: _/_/_ DD/MM/YR Sexual health is an important part of an individual's overall physical and emotional well-being. Erectile dysfunction, also known as impotence, is one type of very common medical condition affecting sexual health. Fortunately, there are many different treatment options for erectile dysfunction. This questionnaire is designed to help you and your doctor identify if you may be experiencing erectile dysfunction. If you are, you may choose to discuss treatment options with your doctor.
Each question has several possible responses. Circle the number of the response that best describes your own situation. Please be sure that you select one and only one response for each question. 3. During sexual intercourse, how often were you able to maintain your erection after you had penetrated (entered) you partner?
Did not attempt intercourse Almost never or never A few times (much less than half the time)
Sometimes (about half the time)
Most times (much more than half the time)
Almost always or always 0 1 2 3 4 5
4. During sexual intercourse, how difficult was it to maintain your erection to completion of intercourse?
Did around the world, and is intended to gauge sexual function over the past 6 months. In addition, the SHIM has been adopted as a standard diagnostic aid for office screening of ED. Responses to each of the five items on the SHIM (Table 1) , which are based on a rating scale from 0 to 5 or from 1 to 5 (depending on the item), are summed to arrive at a total score that can range from 1 to 25, with higher scores indicating better sexual health. Patients with a score of 21 or less may have evidence of ED, and are encouraged to consult a physician for further evaluation and possible treatment of their condition. Among men in a stable relationship (ie men who had an opportunity for sexual activity), classification of ED is partitioned into five severity grades: no ED (SHIM total score, 22-25), mild (17) (18) (19) (20) (21) , mild to moderate (12) (13) (14) (15) (16) , moderate (8) (9) (10) (11) , and severe ED (1-7).
Since publication of the original validation studies, 4, 5 several articles on the SHIM have been published. Obtaining publications from a Medline search (January 1966-November 2004) using the key words 'Sexual Health Inventory for Men' or 'IIEF-5', we provide a comprehensive review of the SHIM with three major objectives: (1) to provide a compendium of studies in which the SHIM was used, (2) to provide a systematic framework to organize and review the studies, and (3) to provide a status report on the SHIM and its impact on the assessment of male sexual function.
Prevalence studies
The Medline search identified 23 articles based on 21 independent studies in which the SHIM was used to estimate the prevalence of ED (Table 2 ). Of these 21 prevalence studies, five (24%) studies involved a diverse group of men from a broad range of clinical practice settings (family services or urological clinics). Men in each study did not share a common chronic disease and could have had none, one, or multiple chronic conditions. The estimated prevalence of ED in these studies was 64% in Leon, Spain; 6 56% in West Virginia, USA; 7 54% in Porto Alegre, Brazil; 8-10 37% in Korea; 11 and 32% with severe or moderate ED in Japan. 12 Four studies involved men from the general population. The estimated prevalence of ED was 32% in France;
13 51% in Rancho Bernardo, California, USA; 14 51% in Singapore; 15 and 36% among healthy men and 52% among men with chronic disease in Japan. 16 These proportions are likely to have been influenced by the age distribution of the sample, which differed from study to study (Table 2) .
The remaining 12 (57%) studies provided the estimated prevalence of ED for patients with a specific chronic disease. 26 and 46% for men with essential hypertension in Spain. 27 Among patients with ED in Beijing, China, 7% had neurogenic ED. 28 The prevalence of ED was generally based on a SHIM score of 21 or less, as recommended, 4, 5 and, when assessed, severity of ED also followed guidelines (no ED, 22-25; mild, 17-21; mild to moderate, 12-16; moderate, 8-11; and severe, 1-7). A few exceptions were noted. Authors of one study specified a SHIM score above 20 as no ED, between 16 and 20 (inclusive) as mild ED, between 11 and 15 as moderate ED, and less than 10 as severe ED. 13 Authors of another study used a variant of the SHIM (the first four questions on the IIEF-5 that address erectile functioning) with severity grades of ED as complete (score of 4 or less), severe (5-10), moderate (11) (12) (13) (14) , and mild (15) (16) (17) (18) , as well as no ED (19) (20) .
14 One group of researchers used a score of less than 21 for ED and subdivided ED arbitrarily into mild (16) (17) (18) (19) (20) , moderate (11) (12) (13) (14) (15) , and severe or complete (10 or less). 15 Another group used scores of 17-21 for mild, 11-16 for mild-to-moderate, 8-10 for moderate, and 7 or less for severe ED. 25 In general, a common theme among the 21 studies reviewed was a relatively high prevalence rate of ED that signified a common and major health problem. When the relationship between ED and its potential risk factors was examined, a higher prevalence of ED was found to be associated with diabetes, depression, vascular disease, hypertension, and increased age, as predicted. Researchers and patients noted that the SHIM was user-friendly, easy to administer, quick, and inexpensive.
Intervention studies
The SHIM was applied as an efficacy measure in 23 studies evaluating an intervention for ED or related conditions (eg Peyronie's disease) ( Table 3 ). In four (17%) of these studies, the sole intervention was surgery and comprised Nesbit operation for Peyronie's disease, 29 venous stripping surgery, 30 prostaImpact of SHIM JC Cappelleri and RC Rosen 31 and surgery for penile fracture. 32 In seven (30%) of the 23 studies, the active interventions included sildenafil for patients with ED, 5, 33 sildenafil plus patient education for patients with ED, [34] [35] [36] sildenafil for patients with ED and arterial hypertension, 37 and, in one study, sildenafil in young healthy men. 38 Five (22%) of the 23 studies featured the evaluation of other oral agents: Butea superba for patients with ED, 39 alpha-blockers or finasteride for patients at high risk for ED, 40 intraurethral alprostadil for patients with ED who were nonresponders to sildenafil, 41 atorvastatin for patients with hypercholesterolemia as the only risk factor for ED, 42 and herbal and vitamin supplements for men who visited a prostate cancer screening clinic. 43 Six (26%) intervention studies involved surgery followed by sildenafil. [44] [45] [46] [47] [48] [49] One (4%) study involved intracorporeal injection for ED caused by radical prostatectomy. 50 In general, the results of the intervention studies using the SHIM indicated a substantial benefit with sildenafil alone, sildenafil plus patient education, and surgical procedures.
All but two studies strictly followed the guidelines proposed for the SHIM from its validation studies. 4, 5 In one study, the 'normal' score used for no ED (26) (27) (28) (29) (30) suggested that the Erectile Function (EF) domain of the IIEF was used instead of the SHIM (or 'IIEF-5'). 38 In another study, a score of less than 21 (instead of less than or equal to 21) was used to classify ED. 40 
Other studies
In eight other studies, which were neither prevalence studies nor intervention studies, the SHIM was used to (1) determine patient inclusion in one study, (2) examine or test correlational hypotheses with potential risk factors of ED in six studies, and (3) evaluate its measurement properties in a specific Krishnan Note: Only the four questions on the erectile functioning of the SHIM were employed in one study. 56 Authors of another study 54 apparently confused the severity classes of the SHIM with that of the six-item EF domain of the IIEF; scores for their severity classes seem to belong to neither the SHIM nor the EF domain.
Impact of SHIM JC Cappelleri and RC Rosen population (Table 4) . Specifically, one of the eight studies used the SHIM to diagnose ED for the purpose of including patients with a positive diagnosis into the study. 51 Six studies, which were correlational studies, addressed the relationship of ED (as measured by SHIM) with a set of risk factors for ED (age, current smoking status, diabetes, depression, hypertension, prostate disease, and cholesterol levels) 52 and with the following: anatomical genital abnormalities; 53 normal response, arterial insufficiency, and venous leakage; 54 the International Prostate Symptom Score; 55 age, body mass index, cholesterol, triglycerides, blood pressure, and fasting blood glucose; 56 and Peyronie's disease. 57 Another study involved the validation of the SHIM for use in Malaysia, and its authors recommended its implementation in clinical practice and research. 58 Authors of one study applied Questions 1-4 on the SHIM (four items on erectile function) rather than all five SHIM items. 56 They partitioned ED into complete (r4), severe (5-10), moderate (11) (12) (13) (14) , mild (15) (16) (17) (18) , and none (19) (20) . Authors of another study apparently confused the severity classes of the SHIM with that of the six-item EF domain of the IIEF. 54 Scores for their severity classes seem to belong to neither the SHIM nor the EF domain.
Discussion
In a few published commentaries, issues were raised concerning the clinical validation and potential applications of the SHIM for diagnostic classification of ED severity. [59] [60] [61] [62] [63] Among the issues discussed were potential cultural differences on how the specific terms in the SHIM are viewed and the application of findings from the SHIM to general practice settings based on scores from men in clinical trials. [59] [60] [61] [62] Also discussed was a lack of difference in SHIM scores among disparate group of patients. 54, 63 As there appears to be some confusion in the literature regarding the selection of items, scoring, and interpretation of the SHIM, we take this opportunity to address and clarify five key areas.
First, among men who attempted sexual intercourse and activity, the original scores of SHIM on disease severity are 22-25 (inclusive) for no ED, 17-21 for mild, 12-16 for mild-to-moderate, 8-11 for moderate, and 5-7 for severe. 4 The score range of 1-7 for severe ED is applicable to men who had the opportunity to engage in sexual activity and intercourse, but whose sexual functioning is so poor that they did not even bother to attempt sexual activity and intercourse. 4, 5, [61] [62] In clinical practice, healthcare professionals should ask patients about their desire and opportunity for sexual activity in order to ensure that low SHIM scores are truly indicative of severe ED. The SHIM is not applicable to men who do not seek or have an opportunity to engage in sexual activity. 61, 62 A low score may be a consequence of a patient having an absence of opportunity or lack of interest in sex, rather than ED per se. Scores on the SHIM should always be placed in the context of the individual patient's circumstances in interpreting the diagnostic significance of the overall score. 62 Second, some confusion exists in the literature concerning the similarities between the SHIM and the full-scale IIEF or its EF domain.
1,2 For instance, one article mistakenly referred to the five domains of the 15-item IIEF as the IIEF-5 (SHIM). 64 Four of the five items on the SHIM are taken from the sixitem EF domain of the IIEF, a validated measure of treatment efficacy. Of the five items on the SHIM, only Item 7 (intercourse satisfaction) is not included in the EF domain. The diagnostic findings, therefore, between the EF domain and the SHIM are expected to be similar. Nonetheless, there are a few methodological differences between the two diagnostic measures. The inclusion of Item 7 on sexual intercourse satisfaction is a distinguishing feature of the SHIM that is absent from the EF domain. Intercourse satisfaction gives a high level of discrimination and addresses a central element in the NIH definition of ED. 3 Items on the SHIM are referenced to the prior 6-month period, which conforms to the NIH's reference period for establishing a diagnosis of ED; in contrast, items in the EF domain have a reference period of 4 weeks. Although the SHIM has merit as a measure of efficacy to evaluate interventions, its primary and intended purpose is for screening and diagnostic severity assessment in clinical practice and in clinical trials as part of study inclusion criteria for ED. The EF domain of the IIEF, which has its own established diagnostic cutoff and severity grades for ED, is preferred over the SHIM to evaluate the efficacy and to assess changes associated with medical treatment of ED in clinical trials. 65, 66 Third, subtle issues exist concerning the validation of the SHIM. [59] [60] [61] [62] Cultural differences on how terms are viewed on the SHIM can be addressed by briefly defining the terms to alleviate the potential ambiguity of words in any screening instrument used in different cultures. Separate validation studies in different countries can also be conducted, as has been done in Malaysia. 58 The cutoff score of 21 on the SHIM was based on diagnostic evaluations of samples from populations in the United States and the United Kingdom. The cutoff score may be the same or differ somewhat in other populations. Although the diagnostic validation of the SHIM included men with ED from clinical trials, the control (non-ED) samples were not part of clinical trials. In addition, many studies from general practice settings covered in this review article suggest that the SHIM has merit for large subpopulations of men, with and without ED, who are similar to those enrolled in the primary validation samples-namely, men in a stable heterosexual relationship who have an opportunity to engage in sexual activity and intercourse. The SHIM is not applicable, however, for use by all men in the general population; for example, it is not designed for use by men who are not sexually active. Another limitation of the SHIM is that, being focused on erectile function, it does not assess sexual desire or orgasm.
Fourth, neither the SHIM nor the IIEF were designed to diagnose the etiology of ED, only its presence and level of severity. Diagnostic tools like the SHIM are not expected to correlate with pharmacological testing and physiologically based assessments, such as Doppler ultrasonography. A body of compelling scientific evidence indicates that pharmacological testing and the duplex Doppler ultrasonography are neither valid nor reliable measures for determining the presence or severity of ED. 67 These tests are known to have low sensitivity, specificity, and reproducibility. 67 Therefore, it is not surprising that physiological or pharmacological tests may be at odds with validated patient reports of sexual dysfunction, including the SHIM. 54, 63 Even if such laboratory tests were accurate for a limited purpose, sexual (and even erectile) dysfunction has multiple facets that extend beyond the limited range of function measured by such laboratory tests.
Fifth, research is lacking on how the SHIM compares with other diagnostic assessments for ED in the same population. Authors of one study reported that the SHIM had relatively high agreement with but better reliability than a single-item self-assessment of ED severity among 247 patients with ED in a double-blind placebo-controlled clinical trial with sildenafil. 5 Authors of another study, in Medline but not captured with the keywords employed in this review, reported that the prevalence of moderate or complete (severe) ED was 36% with the SHIM and 40% with a single self-assessment question for 199 men (mean age ¼ 59 y) selected from general medical practices in Pennsylvania, USA. 68 We recommend more research on how the multiple-item SHIM compares with single-item prevalence measures such as the ones in the MALES study 69 and the MMAS study, 70, 71 as well as multiple-item assessments such as the EF domain of the IIEF. 65, 66 A diagnostic measure that results in a graded severity of ED is favored over a measure that is limited to a categorical measure of the presence or absence of ED. A single-item self-assessment of ED, on the other hand, is likely to yield a higher rate of compliance than a multiple-item assessment in community-based epidemiologic studies.
In addition to the five key areas mentioned above, we note that several articles in which the SHIM was a prominent measure, be they published before or after our Medline search, may not have been included in our review because they were not identified by our Medline search. Excluded articles may have been part of other literature databases, a chapter of a book, or published after our review. For example, the SHIM was administered in a survey of 7689 patients in a recent publication, 72 published in December 2004 and hence after our search of articles. In this survey, the SHIM was pivotal in determining that patients with diabetes or hypertension or both have a high prevalence of bothersome untreated ED who wish their general practitioner to initiate a discussion and provide treatment. 72 Although it is likely that this review covers most studies in which the SHIM was an integral assessment or outcome measure (at least 52 studies of which at least 21 were prevalence studies, 23 were intervention studies, and eight were other clinical (mostly correlational) studies), the reader should realize that not all articles using the SHIM are included. Therefore, the number and scope of the articles in this review can be viewed as a lowerbound contribution that the SHIM has had on male sexual function.
Conclusions
The SHIM is intended to serve as a screening and diagnostic aid and to complement, not supplant, clinical judgment. Although its screening properties are impressive when properly used, it should not be viewed as a perfect diagnostic discriminator. The SHIM is intended to enhance the decision making of clinicians who are likely to perform more detailed evaluations in individual cases.
In this regard, the results using the SHIM and its positive impact on the assessment of male sexual function are well documented in this review. At least 21 studies have used the SHIM to determine the prevalence of ED. In general, researchers noted that the prevalence rate of ED was relatively high and that ED is a common, major health problem. As expected, a higher prevalence of ED was associated with diabetes, depression, vascular disease, hypertension, and increased age. Researchers and patients found the SHIM to be useful, quick, and inexpensive.
Furthermore, the SHIM was incorporated to assess the efficacy of interventions in at least 23 studies. In general, substantial efficacy was found with sildenafil, sildenafil plus patient education, and surgical procedures. The SHIM was also employed in eight other (mainly correlational) studies, which helped to increase understanding of the psychometric properties of the scale. Researchers in some studies investigated and quantified the relationships of ED (as measured by the SHIM) with potential or known risk factors for ED.
We expect the SHIM to continue to enjoy widespread use and clinical utility as a brief screening tool for ED. The quantity of research and the quality of scholarship on the SHIM provide testimony to the utility of the SHIM and its positive scientific impact on understanding and improving male sexual function that, given current trends, is likely to remain influential in coming years.
